GlassScriptPhysician profile
Piamsook Angkeow
NPI 1568439461
$3,584.57
in general payments reported to CMS, 2019-2025
29 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $166 · 2021: $18.67 · 2022: $153 · 2023: $276 · 2024: $535 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $725.65 | 2022-2025 | Na, Linq II, Aurora Ev-Icd Mri Surescan |
| Aop Health US, LLC | $475.75 | 2025 | Rapiblyk |
| Pfizer INC. | $412.38 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $336.78 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $294.70 | 2019-2025 | |
| Boston Scientific Corporation | $195.89 | 2019-2025 | Emblem Mri S-Icd, Versacross Access Solution |
| E.R. Squibb & Sons, L.L.C. | $132.82 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.53 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $110.28 | 2019-2025 | Farxiga, Brilinta |
| Sanofi-Aventis U.S. LLC | $82.48 | 2019 | |
| Amgen INC. | $76.28 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.24 | 2019-2025 | Jardiance |
| Abbott Laboratories | $53.81 | 2025 | Gallant, Aveir |
| Cardiva Medical, INC. | $49.59 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $48.47 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $45.80 | 2025 | Assure Wcd |
| Bardy Diagnostics, INC. | $45.62 | 2019 | |
| Amarin Pharma, INC. | $38.68 | 2019 | |
| Medtronic Vascular, INC. | $34.49 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $32.59 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $27.38 | 2019-2020 | |
| Biotronik INC. | $26.47 | 2024 | Renamic Neo |
| Terumo Medical Corporation | $26.10 | 2025 | Angio-Seal |
| Bayer Healthcare Pharmaceuticals INC. | $25.58 | 2025 | |
| Siemens Medical Solutions USA, INC. | $23.01 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Preventice Services, LLC | $19.63 | 2019 | |
| Esperion Therapeutics, INC. | $18.67 | 2021 | |
| Heartflow, INC. | $17.86 | 2025 | |
| Altathera Pharmaceuticals LLC | $17.04 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piamsook Angkeow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.